Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
74.8M
-
Number of holders
-
153
-
Total 13F shares, excl. options
-
64.8M
-
Shares change
-
+2.59M
-
Total reported value, excl. options
-
$674M
-
Value change
-
+$31M
-
Put/Call ratio
-
0.8
-
Number of buys
-
81
-
Number of sells
-
-52
-
Price
-
$10.39
Significant Holders of Zymeworks Inc. - Common Stock (ZYME) as of Q4 2023
172 filings reported holding ZYME - Zymeworks Inc. - Common Stock as of Q4 2023.
Zymeworks Inc. - Common Stock (ZYME) has 153 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 64.8M shares
of 74.8M outstanding shares and own 86.64% of the company stock.
Largest 10 shareholders include EcoR1 Capital, LLC (13.4M shares), BVF INC/IL (5.87M shares), Redmile Group, LLC (5.79M shares), MORGAN STANLEY (4.86M shares), BlackRock Inc. (3.92M shares), Rubric Capital Management LP (3.48M shares), VANGUARD GROUP INC (2.39M shares), CREDIT SUISSE AG/ (2.3M shares), BNP Paribas Asset Management Holding S.A. (1.77M shares), and FARALLON CAPITAL MANAGEMENT LLC (1.76M shares).
This table shows the top 153 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.